Drug Digest: Large-Molecule Manufacturing Trends

In this exclusive Drug Digest video, experts from several major players in the biologics field summarize current trends, identify key strategies to accelerate early-phase development, share approaches to speeding up timelines for even the most complex formats, and look into the future of advancements in large-molecule manufacturing.

Register Free: https://www.pharmtech.com/pt_w/large-molecule-trends

Event Overview:

As complex formats come to dominate the next generation of biologic drugs, trends in large-molecule manufacturing are evolving. This episode of Drug Digest identifies what those trends are, what are currently some approaches to speeding up development timelines without sacrificing quality, how manufacturers are strategizing to accelerate the earliest stages of development, and what the future holds in terms of next-gen advancements.

Key Learning Objectives:

• What the current trends in large-molecule manufacturing are
• Strategies for accelerating early-phase development while reducing risk
• Approaches to speeding up investigational new drug timelines even for complex formats
• Ways to keep the CMC process flexible and ensure product quality simultaneously

Who Should Attend:

• Biologics developers
• Biologics manufacturers
• Formulation scientists
• Development scientists
• Researchers or innovators with a focus in large molecules

Speaker:

Matthew Minakowski
Director, Commercial
Development, Mammalian,
Integrated Biologics
Lonza

Register Free: https://www.pharmtech.com/pt_w/large-molecule-trends